← Mechanisms of action
CD79B
SINGLE PROTEINHomo sapiens
Preferred name: B-cell antigen receptor complex-associated protein beta chain ChEMBL ↗
Linked proteins
Drugs acting on this target (16)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| jnj-80948543 | Binding agent | experimental | mAb | CD79B binding agent |
| jnj-87801493 | Binding agent | experimental | mAb | CD79B binding agent |
| polatuzumab vedotin (Polivy) | Binding agent | approved | mAb | CD79B binding agent |
| 4scar79b | Immunity, passive | experimental | Cell therapy | CD79B immunity, passive |
| bbt369 | Immunity, passive | experimental | Cell therapy | CD79B immunity, passive |
| bi-4scar cd19/79b t cells | Immunity, passive | experimental | Cell therapy | CD79B immunity, passive |
| cd79b car-t cells | Immunity, passive | experimental | Cell therapy | CD79B immunity, passive |
| cd79b-19 car t cells | Immunity, passive | experimental | Cell therapy | CD79B immunity, passive |
| jv-213 | Immunity, passive | experimental | Cell therapy | CD79B immunity, passive |
| arc-001 | Inhibitor | experimental | Small molecule | CD79B inhibitor |
| dcds0780a | Inhibitor | experimental | mAb | CD79B inhibitor |
| gs-5319 | Inhibitor | experimental | Small molecule | CD79B inhibitor |
| ltz-301 | Inhibitor | experimental | mAb | CD79B inhibitor |
| mgd010 | Inhibitor | experimental | mAb | CD79B inhibitor |
| polatuzumab vedotin (Polivy) | Inhibitor | approved | mAb | CD79B inhibitor |
| prv-3279 | Inhibitor | experimental | mAb | CD79B inhibitor |